1exz
From Proteopedia
m (Protected "1exz" [edit=sysop:move=sysop]) |
|||
Line 1: | Line 1: | ||
- | [[Image:1exz.png|left|200px]] | ||
- | |||
{{STRUCTURE_1exz| PDB=1exz | SCENE= }} | {{STRUCTURE_1exz| PDB=1exz | SCENE= }} | ||
+ | ===STRUCTURE OF STEM CELL FACTOR=== | ||
+ | {{ABSTRACT_PUBMED_10884405}} | ||
- | == | + | ==Disease== |
+ | [[http://www.uniprot.org/uniprot/SCF_HUMAN SCF_HUMAN]] Defects in KITLG are the cause of familial progressive hyperpigmentation (FPH) [MIM:[http://omim.org/entry/145250 145250]]; also called melanosis universalis hereditaria (MUH). FPH is an autosomal-dominantly inherited disorder characterized by hyperpigmented patches in the skin, present in early infancy and increasing in size and number with age.<ref>PMID:19375057</ref> | ||
+ | ==Function== | ||
+ | [[http://www.uniprot.org/uniprot/SCF_HUMAN SCF_HUMAN]] Ligand for the receptor-type protein-tyrosine kinase KIT. Plays an essential role in the regulation of cell survival and proliferation, hematopoiesis, stem cell maintenance, gametogenesis, mast cell development, migration and function, and in melanogenesis. KITLG/SCF binding can activate several signaling pathways. Promotes phosphorylation of PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase, and subsequent activation of the kinase AKT1. KITLG/SCF and KIT also transmit signals via GRB2 and activation of RAS, RAF1 and the MAP kinases MAPK1/ERK2 and/or MAPK3/ERK1. KITLG/SCF and KIT promote activation of STAT family members STAT1, STAT3 and STAT5. KITLG/SCF and KIT promote activation of PLCG1, leading to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. KITLG/SCF acts synergistically with other cytokines, probably interleukins. | ||
==About this Structure== | ==About this Structure== | ||
Line 10: | Line 13: | ||
==Reference== | ==Reference== | ||
- | <ref group="xtra">PMID:010884405</ref><references group="xtra"/> | + | <ref group="xtra">PMID:010884405</ref><references group="xtra"/><references/> |
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Joachimiak, A.]] | [[Category: Joachimiak, A.]] |
Revision as of 02:13, 25 March 2013
Contents |
STRUCTURE OF STEM CELL FACTOR
Template:ABSTRACT PUBMED 10884405
Disease
[SCF_HUMAN] Defects in KITLG are the cause of familial progressive hyperpigmentation (FPH) [MIM:145250]; also called melanosis universalis hereditaria (MUH). FPH is an autosomal-dominantly inherited disorder characterized by hyperpigmented patches in the skin, present in early infancy and increasing in size and number with age.[1]
Function
[SCF_HUMAN] Ligand for the receptor-type protein-tyrosine kinase KIT. Plays an essential role in the regulation of cell survival and proliferation, hematopoiesis, stem cell maintenance, gametogenesis, mast cell development, migration and function, and in melanogenesis. KITLG/SCF binding can activate several signaling pathways. Promotes phosphorylation of PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase, and subsequent activation of the kinase AKT1. KITLG/SCF and KIT also transmit signals via GRB2 and activation of RAS, RAF1 and the MAP kinases MAPK1/ERK2 and/or MAPK3/ERK1. KITLG/SCF and KIT promote activation of STAT family members STAT1, STAT3 and STAT5. KITLG/SCF and KIT promote activation of PLCG1, leading to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. KITLG/SCF acts synergistically with other cytokines, probably interleukins.
About this Structure
1exz is a 4 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
- Zhang Z, Zhang R, Joachimiak A, Schlessinger J, Kong XP. Crystal structure of human stem cell factor: implication for stem cell factor receptor dimerization and activation. Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):7732-7. PMID:10884405
- ↑ Wang ZQ, Si L, Tang Q, Lin D, Fu Z, Zhang J, Cui B, Zhu Y, Kong X, Deng M, Xia Y, Xu H, Le W, Hu L, Kong X. Gain-of-function mutation of KIT ligand on melanin synthesis causes familial progressive hyperpigmentation. Am J Hum Genet. 2009 May;84(5):672-7. doi: 10.1016/j.ajhg.2009.03.019. Epub 2009 , Apr 16. PMID:19375057 doi:10.1016/j.ajhg.2009.03.019